CHI3L1 and Alzheimer disease: The CSF levels of YKL-40 were also previously demonstrated as being increased in the CSF of MCI-AD patients compared to stable MCI, therefore this protein could be used as a biomarker for the prognosis of mild cognitive impairment and the likelihood of progression to AD [21].